Additional Information About Drug Price Negotiation and CBO’s Simulation Model of Drug Development

Report
United States Capitol Building in Washington, DC

In response to a request from Budget Committee Chairman Jodey Arrington and Congressman Michael C. Burgess, CBO provides information about its analysis of federal policies that affect the development of new drugs in the United States.

View Document
326.52 KB

Data and Supplemental Information